Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
The Schmooze

Mouse Sperm Breakthrough Could Help Cure Infertility

In a tale of mice and men, Ben-Gurion University of the Negev researchers have made a breakthrough in rodents that could eventually help infertile male humans. The group, led by professor Mahmoud Huleihel, has produced mouse sperm from germ cells using in-vitro techniques.

The researchers at Shraga Segal Department of Microbiology and Immunology in the Faculty of Health Sciences in Beersheba, in cooperation with professor Eitan Lunenfeld at Soroka University Medical Center and professor Stefan Schlatt of the University of Münster in Germany, pioneered a three-dimensional cell culture system on a bed of agar to produce sperm from the germ cells. The Jerusalem Post reports that Huleihel believes that the three-dimensional cell culture system succeeded where previously-tried two-dimensional systems did not, because it uses soft agar that closely replicates the natural environment in the male mouse’s testes where the final stages of spermatogenesis normally take place.

While it is too soon to move into human experimentation with this technique, the researchers are hopeful that their discovery will eventually lead to treatments to help infertile men, or boys who risk infertility by having to undergo medical treatments that could damage their ability to produce healthy sperm later in life.

A message from our Publisher & CEO Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.